Phase I Pharmacokinetic and Pharmacodynamic Study of Cetuximab, Irinotecan and Sorafenib in Advanced Colorectal Cancer

BACKGROUND: This phase Ib study was designed to determine the maximum tolerated doses (MTD) and dose limiting toxicities (DLTs) of irinotecan and cetuximab with sorafenib. Secondary objectives included characterizing the pharmacokinetics and pharmacodynamics and evaluating preliminary antitumor acti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Azad, Nilofer, Dasari, Arvind, Arcaroli, John, Taylor, Gretchen E., Laheru, Daniel A., Carducci, Michael A., McManus, Martine, Quackenbush, Kevin, Wright, John J., Hidalgo, Manuel, Diaz, Luis A., Donehower, Ross C., Zhao, Ming, Rudek, Michelle A., Messersmith, Wells A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674958/
https://ncbi.nlm.nih.gov/pubmed/22615057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9820-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados